Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs
被引:66
|
作者:
Beloqui, Ana
论文数: 0引用数: 0
h-index: 0
机构:
Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, BelgiumCatholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium
Beloqui, Ana
[1
]
论文数: 引用数:
h-index:
机构:
del Pozo-Rodriguez, Ana
[2
]
论文数: 引用数:
h-index:
机构:
Isla, Arantxazu
[2
]
Rodriguez-Gascon, Alicia
论文数: 0引用数: 0
h-index: 0
机构:
Univ Basque Country, Pharmacokinet Nanotechnol & Gene Therapy Grp Phar, Fac Pharm, UPV EHU,Lascaray Res Ctr, Paseo Univ 7, Vitoria 01006, SpainCatholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium
Rodriguez-Gascon, Alicia
[2
]
论文数: 引用数:
h-index:
机构:
Angeles Solinis, Maria
[2
]
机构:
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium
Poorly water soluble (PWS) drugs lack from good oral absorption, which limits their oral administration, the most common drug delivery route. The design of appropriate innovative formulations for PWS drugs will allow for adequate bioavailability, reduction of the required dose and oral delivery of drugs that would otherwise need the parenteral route. Among the formulations under study, Nanostructured Lipid Carriers (NLCs), made of biocompatible mixtures of solid and liquid lipids, represent a good choice. NLCs enhance the apparent solubility and dissolution of PWS drugs in the gastrointestinal tract, and/or modulate the drug permeability and fate across the intestinal barrier, opening new perspectives in the field of innovative medicines for oral administration of PWS molecules. Recently, NLCs have also emerged as a promising anti-inflammatory drug delivery system for inflammatory bowel diseases. The present paper is focused on the state of the art of NLCs for oral delivery of PWS drugs. The design, the main preparation techniques and the mechanisms through the drug oral delivery is improved by NLCs are presented, highlighting the influence of the most relevant technological and formulation factors on the properties of the NLCs, which condition their efficacy as oral delivery formulations. (C) 2017 Elsevier B.V. All rights reserved.
机构:
Fernando Pessoa Univ, Fac Hlth Sci, P-4200150 Oporto, Portugal
Univ Porto, Fac Pharm, Ctr Res Pharmaceut Sci, Lab Pharmaceut Technol, P-4050313 Oporto, PortugalFernando Pessoa Univ, Fac Hlth Sci, P-4200150 Oporto, Portugal
Silva, A. C.
论文数: 引用数:
h-index:
机构:
Santos, D.
Ferreira, D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Porto, Fac Pharm, Ctr Res Pharmaceut Sci, Lab Pharmaceut Technol, P-4050313 Oporto, PortugalFernando Pessoa Univ, Fac Hlth Sci, P-4200150 Oporto, Portugal
Ferreira, D.
Lopes, C. M.
论文数: 0引用数: 0
h-index: 0
机构:
Fernando Pessoa Univ, Fac Hlth Sci, P-4200150 Oporto, Portugal
Tras Os Montes & Alto Douro Univ IBB CGB UTAD, Ctr Genet & Biotechnol, Inst Biotechnol & Bioengn, Vila Real, PortugalFernando Pessoa Univ, Fac Hlth Sci, P-4200150 Oporto, Portugal